Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 278 entries
Sorted by: Best Match Show Resources per page
Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy.

BMC clinical pathology

Hutchison CA, Cockwell P, Cook M.
PMID: 22873484
BMC Clin Pathol. 2012 Aug 09;12:12. doi: 10.1186/1472-6890-12-12.

BACKGROUND: The development of serum immunoassays for the measurement of immunoglobulin free light chains has led to a paradigm shift in the diagnosis, assessment and monitoring of patients with plasma cell dyscrasias. The impact of these immunoassays which employ...

Cite
Hutchison CA, Cockwell P, Cook M. Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy. BMC Clin Pathol. 2012;12:12doi: 10.1186/1472-6890-12-12.
Hutchison, C. A., Cockwell, P., & Cook, M. (2012). Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy. BMC clinical pathology, 1212. https://doi.org/10.1186/1472-6890-12-12
Hutchison, Colin A, et al. "Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy." BMC clinical pathology vol. 12 (2012): 12. doi: https://doi.org/10.1186/1472-6890-12-12
Hutchison CA, Cockwell P, Cook M. Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy. BMC Clin Pathol. 2012 Aug 09;12:12. doi: 10.1186/1472-6890-12-12. PMID: 22873484; PMCID: PMC3507768.
Copy Download .nbib Format: NLM
Primary adenocarcinoma of the thymus: an immunohistochemical and molecular study with review of the literature.

BMC clinical pathology

Maghbool M, Ramzi M, Nagel I, Bejarano P, Siebert R, Saeedzadeh A, Daneshbod Y.
PMID: 23725376
BMC Clin Pathol. 2013 May 31;13(1):17. doi: 10.1186/1472-6890-13-17.

BACKGROUND: Primary adenocarcinoma of thymus is extremely rare.CASE PRESENTATION: This is a case of primary adenocarcinoma with intestinal differentiation and focal mucin production in the thymus. Thymic cyst was associated with this tumor. Intestinal differentiation was confirmed by immunohistochemical...

Cite
Maghbool M, Ramzi M, Nagel I, et al. Primary adenocarcinoma of the thymus: an immunohistochemical and molecular study with review of the literature. BMC Clin Pathol. 2013;13(1):17doi: 10.1186/1472-6890-13-17.
Maghbool, M., Ramzi, M., Nagel, I., Bejarano, P., Siebert, R., Saeedzadeh, A., & Daneshbod, Y. (2013). Primary adenocarcinoma of the thymus: an immunohistochemical and molecular study with review of the literature. BMC clinical pathology, 13(1), 17. https://doi.org/10.1186/1472-6890-13-17
Maghbool, Maryam, et al. "Primary adenocarcinoma of the thymus: an immunohistochemical and molecular study with review of the literature." BMC clinical pathology vol. 13,1 (2013): 17. doi: https://doi.org/10.1186/1472-6890-13-17
Maghbool M, Ramzi M, Nagel I, Bejarano P, Siebert R, Saeedzadeh A, Daneshbod Y. Primary adenocarcinoma of the thymus: an immunohistochemical and molecular study with review of the literature. BMC Clin Pathol. 2013 May 31;13(1):17. doi: 10.1186/1472-6890-13-17. PMID: 23725376; PMCID: PMC3672093.
Copy Download .nbib Format: NLM
Relapsed angioimmunoblastic T-cell lymphoma with acquired expression of CD20: a case report and review of the literature.

BMC clinical pathology

Banz Y, Krasniqi F, Dirnhofer S, Tzankov A.
PMID: 23738899
BMC Clin Pathol. 2013 Jun 05;13:18. doi: 10.1186/1472-6890-13-18.

BACKGROUND: Angioimmunoblastic T-cell lymphoma is one of the most common types of peripheral T-cell lymphomas, usually presenting at an older age with an aggressive clinical course. Its characteristic morphological presentation and follicular helper T-cell phenotype help to distinguish it...

Cite
Banz Y, Krasniqi F, Dirnhofer S, et al. Relapsed angioimmunoblastic T-cell lymphoma with acquired expression of CD20: a case report and review of the literature. BMC Clin Pathol. 2013;13:18doi: 10.1186/1472-6890-13-18.
Banz, Y., Krasniqi, F., Dirnhofer, S., & Tzankov, A. (2013). Relapsed angioimmunoblastic T-cell lymphoma with acquired expression of CD20: a case report and review of the literature. BMC clinical pathology, 1318. https://doi.org/10.1186/1472-6890-13-18
Banz, Yara, et al. "Relapsed angioimmunoblastic T-cell lymphoma with acquired expression of CD20: a case report and review of the literature." BMC clinical pathology vol. 13 (2013): 18. doi: https://doi.org/10.1186/1472-6890-13-18
Banz Y, Krasniqi F, Dirnhofer S, Tzankov A. Relapsed angioimmunoblastic T-cell lymphoma with acquired expression of CD20: a case report and review of the literature. BMC Clin Pathol. 2013 Jun 05;13:18. doi: 10.1186/1472-6890-13-18. PMID: 23738899; PMCID: PMC3680012.
Copy Download .nbib Format: NLM
Dried blood spot omega-3 and omega-6 long chain polyunsaturated fatty acid levels in 7-9 year old Zimbabwean children: a cross sectional study.

BMC clinical pathology

Mashavave G, Kuona P, Tinago W, Stray-Pedersen B, Munjoma M, Musarurwa C.
PMID: 27499701
BMC Clin Pathol. 2016 Aug 05;16:14. doi: 10.1186/s12907-016-0035-7. eCollection 2016.

BACKGROUND: Omega-3 long chain-polyunsaturated fatty acids (LC-PUFAs)-docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and eicosapentaenoic acid (EPA)- and omega-6 LC-PUFA arachidonic acid (ARA), are essential for optimum physical and mental development in children. Prior to this study, the blood omega-3...

Cite
Mashavave G, Kuona P, Tinago W, et al. Dried blood spot omega-3 and omega-6 long chain polyunsaturated fatty acid levels in 7-9 year old Zimbabwean children: a cross sectional study. BMC Clin Pathol. 2016;16:14doi: 10.1186/s12907-016-0035-7.
Mashavave, G., Kuona, P., Tinago, W., Stray-Pedersen, B., Munjoma, M., & Musarurwa, C. (2016). Dried blood spot omega-3 and omega-6 long chain polyunsaturated fatty acid levels in 7-9 year old Zimbabwean children: a cross sectional study. BMC clinical pathology, 1614. https://doi.org/10.1186/s12907-016-0035-7
Mashavave, Grace, et al. "Dried blood spot omega-3 and omega-6 long chain polyunsaturated fatty acid levels in 7-9 year old Zimbabwean children: a cross sectional study." BMC clinical pathology vol. 16 (2016): 14. doi: https://doi.org/10.1186/s12907-016-0035-7
Mashavave G, Kuona P, Tinago W, Stray-Pedersen B, Munjoma M, Musarurwa C. Dried blood spot omega-3 and omega-6 long chain polyunsaturated fatty acid levels in 7-9 year old Zimbabwean children: a cross sectional study. BMC Clin Pathol. 2016 Aug 05;16:14. doi: 10.1186/s12907-016-0035-7. eCollection 2016. PMID: 27499701; PMCID: PMC4974798.
Copy Download .nbib Format: NLM
Accuracy of cervical cytology: comparison of diagnoses of 100 Pap smears read by four pathologists at three hospitals in Norway.

BMC clinical pathology

Sørbye SW, Suhrke P, Revå BW, Berland J, Maurseth RJ, Al-Shibli K.
PMID: 28860942
BMC Clin Pathol. 2017 Aug 29;17:18. doi: 10.1186/s12907-017-0058-8. eCollection 2017.

BACKGROUND: Cervical cancer can be prevented by early detection and treatment for precancerous lesions. Since 1995, there has been a national cervical cancer screening program in Norway, where women aged 25-69 years are recommended to take Pap smears every...

Cite
Sørbye SW, Suhrke P, Revå BW, et al. Accuracy of cervical cytology: comparison of diagnoses of 100 Pap smears read by four pathologists at three hospitals in Norway. BMC Clin Pathol. 2017;17:18doi: 10.1186/s12907-017-0058-8.
Sørbye, S. W., Suhrke, P., Revå, B. W., Berland, J., Maurseth, R. J., & Al-Shibli, K. (2017). Accuracy of cervical cytology: comparison of diagnoses of 100 Pap smears read by four pathologists at three hospitals in Norway. BMC clinical pathology, 1718. https://doi.org/10.1186/s12907-017-0058-8
Sørbye, Sveinung Wergeland, et al. "Accuracy of cervical cytology: comparison of diagnoses of 100 Pap smears read by four pathologists at three hospitals in Norway." BMC clinical pathology vol. 17 (2017): 18. doi: https://doi.org/10.1186/s12907-017-0058-8
Sørbye SW, Suhrke P, Revå BW, Berland J, Maurseth RJ, Al-Shibli K. Accuracy of cervical cytology: comparison of diagnoses of 100 Pap smears read by four pathologists at three hospitals in Norway. BMC Clin Pathol. 2017 Aug 29;17:18. doi: 10.1186/s12907-017-0058-8. eCollection 2017. PMID: 28860942; PMCID: PMC5576325.
Copy Download .nbib Format: NLM
Bone pathologic fracture revealing an unusual association: coexistence of Langerhans cell histiocytosis with Rosai-Dorfman disease.

BMC clinical pathology

Efared B, Mazti A, Chaibou B, Atsame-Ebang G, Sidibé IS, Tahiri L, Erregad F, Hammas N, El Mrini A, El Fatemi H, Chbani L.
PMID: 28396615
BMC Clin Pathol. 2017 Apr 07;17:5. doi: 10.1186/s12907-017-0044-1. eCollection 2017.

BACKGROUND: The coexistence of Rosai-Dorfman disease (RDD) with Langerhans cell histiocytosis (LCH) is very rare, as to date only 17 cases have been reported in the english literature. The pathophysiology of this uncommon co-occurrence still remains enigmatic and a...

Cite
Efared B, Mazti A, Chaibou B, et al. Bone pathologic fracture revealing an unusual association: coexistence of Langerhans cell histiocytosis with Rosai-Dorfman disease. BMC Clin Pathol. 2017;17:5doi: 10.1186/s12907-017-0044-1.
Efared, B., Mazti, A., Chaibou, B., Atsame-Ebang, G., Sidibé, I. S., Tahiri, L., Erregad, F., Hammas, N., El Mrini, A., El Fatemi, H., & Chbani, L. (2017). Bone pathologic fracture revealing an unusual association: coexistence of Langerhans cell histiocytosis with Rosai-Dorfman disease. BMC clinical pathology, 175. https://doi.org/10.1186/s12907-017-0044-1
Efared, Boubacar, et al. "Bone pathologic fracture revealing an unusual association: coexistence of Langerhans cell histiocytosis with Rosai-Dorfman disease." BMC clinical pathology vol. 17 (2017): 5. doi: https://doi.org/10.1186/s12907-017-0044-1
Efared B, Mazti A, Chaibou B, Atsame-Ebang G, Sidibé IS, Tahiri L, Erregad F, Hammas N, El Mrini A, El Fatemi H, Chbani L. Bone pathologic fracture revealing an unusual association: coexistence of Langerhans cell histiocytosis with Rosai-Dorfman disease. BMC Clin Pathol. 2017 Apr 07;17:5. doi: 10.1186/s12907-017-0044-1. eCollection 2017. PMID: 28396615; PMCID: PMC5383940.
Copy Download .nbib Format: NLM
Cellular angiofibroma of the vulva: a poorly known entity, a case report and literature review.

BMC clinical pathology

Khmou M, Lamalmi N, Malihy A, Rouas L, Alhamany Z.
PMID: 27274709
BMC Clin Pathol. 2016 Jun 04;16:8. doi: 10.1186/s12907-016-0030-z. eCollection 2016.

BACKGROUND: Cellular angiofibroma represents a newly described, site specific tumor. Histologically, CAF is a benign mesenchymal neoplasm characterized by two principal components: bland spindle cells and prominent small to medium-sized vessels with mural hyalinization. The indolent nature of the...

Cite
Khmou M, Lamalmi N, Malihy A, et al. Cellular angiofibroma of the vulva: a poorly known entity, a case report and literature review. BMC Clin Pathol. 2016;16:8doi: 10.1186/s12907-016-0030-z.
Khmou, M., Lamalmi, N., Malihy, A., Rouas, L., & Alhamany, Z. (2016). Cellular angiofibroma of the vulva: a poorly known entity, a case report and literature review. BMC clinical pathology, 168. https://doi.org/10.1186/s12907-016-0030-z
Khmou, Mouna, et al. "Cellular angiofibroma of the vulva: a poorly known entity, a case report and literature review." BMC clinical pathology vol. 16 (2016): 8. doi: https://doi.org/10.1186/s12907-016-0030-z
Khmou M, Lamalmi N, Malihy A, Rouas L, Alhamany Z. Cellular angiofibroma of the vulva: a poorly known entity, a case report and literature review. BMC Clin Pathol. 2016 Jun 04;16:8. doi: 10.1186/s12907-016-0030-z. eCollection 2016. PMID: 27274709; PMCID: PMC4893283.
Copy Download .nbib Format: NLM
Evaluation of SD BIOLINE .

BMC clinical pathology

Negash M, Kassu A, Amare B, Yismaw G, Moges B.
PMID: 29515332
BMC Clin Pathol. 2018 Mar 05;18:4. doi: 10.1186/s12907-018-0071-6. eCollection 2018.

METHODS: Stool samples were collected to analyse the diagnostic performance of SD BIOLINE RESULTS: Stool and serum samples were collected from 201 dyspeptic patients and analysed. The sensitivity, specificity, positive and negative predictive values of the SD BIOLINE CONCLUSION:...

Cite
Negash M, Kassu A, Amare B, et al. Evaluation of SD BIOLINE . BMC Clin Pathol. 2018;18:4doi: 10.1186/s12907-018-0071-6.
Negash, M., Kassu, A., Amare, B., Yismaw, G., & Moges, B. (2018). Evaluation of SD BIOLINE . BMC clinical pathology, 184. https://doi.org/10.1186/s12907-018-0071-6
Negash, Markos, et al. "Evaluation of SD BIOLINE ." BMC clinical pathology vol. 18 (2018): 4. doi: https://doi.org/10.1186/s12907-018-0071-6
Negash M, Kassu A, Amare B, Yismaw G, Moges B. Evaluation of SD BIOLINE . BMC Clin Pathol. 2018 Mar 05;18:4. doi: 10.1186/s12907-018-0071-6. eCollection 2018. PMID: 29515332; PMCID: PMC5836355.
Copy Download .nbib Format: NLM
Erratum: Increased fatty acid synthase expression in prostate biopsy cores predicts higher Gleason score in radical prostatectomy specimen.

BMC clinical pathology

Hamada S, Horiguchi A, Kuroda K, Ito K, Asano T, Miyai K, Iwaya K.
PMID: 25972764
BMC Clin Pathol. 2015 May 13;15:7. doi: 10.1186/s12907-015-0007-3. eCollection 2015.

[This corrects the article DOI: 10.1186/1472-6890-14-3.].

Cite
Hamada S, Horiguchi A, Kuroda K, et al. Erratum: Increased fatty acid synthase expression in prostate biopsy cores predicts higher Gleason score in radical prostatectomy specimen. BMC Clin Pathol. 2015;15:7doi: 10.1186/s12907-015-0007-3.
Hamada, S., Horiguchi, A., Kuroda, K., Ito, K., Asano, T., Miyai, K., & Iwaya, K. (2015). Erratum: Increased fatty acid synthase expression in prostate biopsy cores predicts higher Gleason score in radical prostatectomy specimen. BMC clinical pathology, 157. https://doi.org/10.1186/s12907-015-0007-3
Hamada, Shinsuke, et al. "Erratum: Increased fatty acid synthase expression in prostate biopsy cores predicts higher Gleason score in radical prostatectomy specimen." BMC clinical pathology vol. 15 (2015): 7. doi: https://doi.org/10.1186/s12907-015-0007-3
Hamada S, Horiguchi A, Kuroda K, Ito K, Asano T, Miyai K, Iwaya K. Erratum: Increased fatty acid synthase expression in prostate biopsy cores predicts higher Gleason score in radical prostatectomy specimen. BMC Clin Pathol. 2015 May 13;15:7. doi: 10.1186/s12907-015-0007-3. eCollection 2015. PMID: 25972764; PMCID: PMC4430029.
Copy Download .nbib Format: NLM
Expression of integrin genes and proteins in progression and dissemination of colorectal adenocarcinoma.

BMC clinical pathology

Denadai MV, Viana LS, Affonso RJ, Silva SR, Oliveira ID, Toledo SR, Matos D.
PMID: 23705994
BMC Clin Pathol. 2013 May 24;13:16. doi: 10.1186/1472-6890-13-16. eCollection 2013.

BACKGROUND: This study aimed to evaluate the relationship between the expression levels of selected integrin genes and proteins and cell differentiation, TNM stage, histological type and other variables potentially associated with the progression and dissemination of colorectal carcinoma (CRC).METHODS:...

Cite
Denadai MV, Viana LS, Affonso RJ, et al. Expression of integrin genes and proteins in progression and dissemination of colorectal adenocarcinoma. BMC Clin Pathol. 2013;13:16doi: 10.1186/1472-6890-13-16.
Denadai, M. V., Viana, L. S., Affonso, R. J., Silva, S. R., Oliveira, I. D., Toledo, S. R., & Matos, D. (2013). Expression of integrin genes and proteins in progression and dissemination of colorectal adenocarcinoma. BMC clinical pathology, 1316. https://doi.org/10.1186/1472-6890-13-16
Denadai, Marcos Va, et al. "Expression of integrin genes and proteins in progression and dissemination of colorectal adenocarcinoma." BMC clinical pathology vol. 13 (2013): 16. doi: https://doi.org/10.1186/1472-6890-13-16
Denadai MV, Viana LS, Affonso RJ, Silva SR, Oliveira ID, Toledo SR, Matos D. Expression of integrin genes and proteins in progression and dissemination of colorectal adenocarcinoma. BMC Clin Pathol. 2013 May 24;13:16. doi: 10.1186/1472-6890-13-16. eCollection 2013. PMID: 23705994; PMCID: PMC3671190.
Copy Download .nbib Format: NLM
Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients.

BMC clinical pathology

Gustbée E, Tryggvadottir H, Markkula A, Simonsson M, Nodin B, Jirström K, Rose C, Ingvar C, Borgquist S, Jernström H.
PMID: 26109908
BMC Clin Pathol. 2015 May 20;15:8. doi: 10.1186/s12907-015-0008-2. eCollection 2015.

BACKGROUND: The mevalonate pathway synthetizes cholesterol, steroid hormones, and non-steriod isoprenoids necessary for cell survival. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) is the rate-limiting enzyme of the mevalonate pathway and the target for statin treatment. HMGCR expression in breast tumors has...

Cite
Gustbée E, Tryggvadottir H, Markkula A, et al. Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients. BMC Clin Pathol. 2015;15:8doi: 10.1186/s12907-015-0008-2.
Gustbée, E., Tryggvadottir, H., Markkula, A., Simonsson, M., Nodin, B., Jirström, K., Rose, C., Ingvar, C., Borgquist, S., & Jernström, H. (2015). Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients. BMC clinical pathology, 158. https://doi.org/10.1186/s12907-015-0008-2
Gustbée, Emma, et al. "Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients." BMC clinical pathology vol. 15 (2015): 8. doi: https://doi.org/10.1186/s12907-015-0008-2
Gustbée E, Tryggvadottir H, Markkula A, Simonsson M, Nodin B, Jirström K, Rose C, Ingvar C, Borgquist S, Jernström H. Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients. BMC Clin Pathol. 2015 May 20;15:8. doi: 10.1186/s12907-015-0008-2. eCollection 2015. PMID: 26109908; PMCID: PMC4479235.
Copy Download .nbib Format: NLM
Autologous anti-SOX2 antibody responses reflect intensity but not frequency of antigen expression in small cell lung cancer.

BMC clinical pathology

Atakan S, Bayiz H, Sak S, Poyraz A, Vural B, Yildirim AS, Demirag F, Gure AO.
PMID: 24940116
BMC Clin Pathol. 2014 Jun 07;14:24. doi: 10.1186/1472-6890-14-24. eCollection 2014.

BACKGROUND: Anti-SOX2 antibody responses are observed in about 10 to 20% of small cell lung cancer (SCLC) patients. The aim of this study was to determine whether such responses reflect a particular pattern of SOX2 protein expression in the...

Cite
Atakan S, Bayiz H, Sak S, et al. Autologous anti-SOX2 antibody responses reflect intensity but not frequency of antigen expression in small cell lung cancer. BMC Clin Pathol. 2014;14:24doi: 10.1186/1472-6890-14-24.
Atakan, S., Bayiz, H., Sak, S., Poyraz, A., Vural, B., Yildirim, A. S., Demirag, F., & Gure, A. O. (2014). Autologous anti-SOX2 antibody responses reflect intensity but not frequency of antigen expression in small cell lung cancer. BMC clinical pathology, 1424. https://doi.org/10.1186/1472-6890-14-24
Atakan, Sukru, et al. "Autologous anti-SOX2 antibody responses reflect intensity but not frequency of antigen expression in small cell lung cancer." BMC clinical pathology vol. 14 (2014): 24. doi: https://doi.org/10.1186/1472-6890-14-24
Atakan S, Bayiz H, Sak S, Poyraz A, Vural B, Yildirim AS, Demirag F, Gure AO. Autologous anti-SOX2 antibody responses reflect intensity but not frequency of antigen expression in small cell lung cancer. BMC Clin Pathol. 2014 Jun 07;14:24. doi: 10.1186/1472-6890-14-24. eCollection 2014. PMID: 24940116; PMCID: PMC4060123.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 278 entries